Emma Guttman-Yassky of Icahn School of Medicine Talks Developments in Atopic Dermatitis Treatment

Emma Guttman-Yassky, M.D., Ph.D. of Icahn School of Medicine at Mount Sinai, New York discussed developments in atopic dermatitis treatment, more specifically with therapies like rocatinlimab and other anti-OX4 agents today at the annual American Academy of Dermatology meeting in New Orleans.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.